Huntsville, Alabama — February 9, 2017 —iCubate®, a molecular diagnostic company, has hired David Lockhart, MT (ASCP) as the company’s Director of Sales and Marketing. Mr. Lockhart has extensive experience in clinical diagnostic sales, marketing and business development. In his years of experience in this field, Mr. Lockhart has worked for a number of key market players including ThermoFisher Scientific, Becton Dickinson, Quidel and Zeptometrix. Mr. Lockhart is the current president of the Southeastern Association for Clinical Microbiology (SEACM).

“David brings a wealth of experience to iCubate. His work in the diagnostic field will add tremendous value as iCubate grows,” said Carter Wells, CEO of iCubate. “All of us at iCubate are excited about the expertise and energy David brings to the company”.

Mr. Lockhart has built a successful sales career for clinical and research laboratory products. He has also launched new products and equipment to clinical microbiology, molecular and research markets. Mr. Lockhart is a medical technologist with a Masters Degree in Medical Laboratory Science with a specialization in clinical microbiology.

“The iCubate system and family of products will soon benefit the clinical microbiology lab and in multiple research settings. The excitement around iCubate is growing and I am thrilled to bring these products to market,” said Lockhart.

 

About iCubate®: iCubate®, Incorporated is a privately-held molecular diagnostic company based in Huntsville, Ala. The company is housed in the HudsonAlpha Institute for Biotechnology. The integrated iCubate System enables extraction, multiplexed amplification and detection automatically in a closed and disposable cassette. Currently, iCubate® products are available for non-clinical, research-use only. See icubate.com for more information.

About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to innovating in the field of genomic technology and sciences across a spectrum of biological challenges. Its mission is four-fold: sparking scientific discoveries that can impact human health and well-being; bringing genomic medicine into clinical care; fostering life sciences entrepreneurship and business growth; and encouraging the creation of a genomics-literate workforce and society.  Designed to be a hothouse of biotech economic development, HudsonAlpha’s state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. The relationships formed on the HudsonAlpha campus encourage collaborations that produce advances in medicine and agriculture. To learn more about HudsonAlpha, visit: www.hudsonalpha.org.

Media contact:
Margetta Thomas
Tel: 256-327-0425
Email: mthomas@hudsonalpha.org

 

 

Navigation

Color Skin